Skip to main content
. 2024 Jan 29;13(3):e6933. doi: 10.1002/cam4.6933

TABLE 2.

Univariate and multivariate survival analysis for disease‐free survival (DFS) in HCC patients.

Variables Univariate analysis Multivariate analysis
HR (95% CI) p‐value HR (95% CI) p‐value
Gender 0.88 (0.70–1.10) 0.256
Age (year) 0.99 (0.98–1.00) 0.005
HBV (yes) 1.16 (0.92–1.45) 0.202
Hepatocirrhosis (yes) 1.23 (1.02–1.47) 0.028 1.25 (1.03, 1.52) 0.023
Child‐Pugh grade (2) 1.44 (1.02–2.05) 0.041
AFP (ng/mL) 1.00 (1.00–1.00) 0.000 1.00 (1.00, 1.00) <0.001
ALT (U/L) 1.00 (1.00–1.00) 0.016
AST (U/L) 1.00 (1.00–1.00) 0.000
GGT (U/L) 1.00 (1.00–1.00) 0.000
ALP (U/L) 1.00 (1.00–1.00) 0.120
ALB (g/L) 0.97 (0.95–0.99) 0.000
TBIL (μmol/L) 1.01 (1.00–1.01) 0.095
PT (s) 1.04 (0.98–1.11) 0.170
PLT (109/L) 1.00 (1.00–1.00) 0.203
WBC (109/L) 1.00 (0.98–1.02) 0.776
HGB (g/L) 1.00 (1.00–1.01) 0.119
NLR 1.03 (1.00–1.05) 0.016
LMR 1.01 (1.00–1.02) 0.037 1.01 (1.00, 1.02) 0.007
PLR 1.00 (1.00–1.00) 0.003
MVI‐positive 2.99 (2.53–3.53) 0.000 2.02 (1.69, 2.42) <0.001
Tumor boundary 0.81 (0.68–0.95) 0.012
Tumor diameter (mm) 1.01 (1.01–1.01) 0.000 1.01 (1.01, 1.01) <0.001
Tumor number
1 Reference
2 1.51 (1.13–2.02) 0.005
≥3 2.49 (1.87–3.31) 0.000
BCLC grade
0 Reference
1 2.23 (1.45–3.42) 0.000
2 6.37 (4.07–9.96) 0.000

Abbreviations: AFP, alpha‐fetoprotein; ALB, albumin; ALP, alkaline phosphatase; ALT, alanine transaminase; AST, aspartate aminotransferase; BCLC, Barcelona clinic liver cancer; GGT, gamma‐glutamyl transpeptidase; HBV, hepatitis B; HCC, hepatocellular carcinoma; HGB, hemoglobin; LMR, lymphocyte‐to‐monocyte ratio; MVI, microvascular invasion; NLR, neutrophil‐to‐lymphocyte ratio; PLR, platelet–lymphocyte ratio; PLT, platelets; PT, prothrombin time; TBIL, total bilirubin; WBC, white blood cells.